Liminatus Pharma, Inc. (LIMN)

0.2299 -0.01 (-3.77%) USD  |  NASDAQ  |  Feb 26, 16:00
0.239 +0.01 (+3.96%) After-Hours: 05:40
More

Liminatus Pharma Return on Equity (3y Mean)

Return on Equity (3y Mean) Chart

View Return on Equity (3y Mean) for LIMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Equity (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Equity (3y Mean) Range, Past 5 Years

View Return on Equity (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Equity (3y Mean) Benchmarks

View Return on Equity (3y Mean) Benchmarks
Start Trial
CDT Equity, Inc. --
LENZ Therapeutics, Inc. Upgrade
Oruka Therapeutics, Inc. Upgrade
Maze Therapeutics, Inc. --
MapLight Therapeutics, Inc. --